Novus Acquisition & Development Corporation (NDEV), a Nevada based enterprise, and a California supplemental insurance carrier and aggregator offer cannabis as a part of consumers’ health insurance plans.
Novus’ business model is the first of its kind in the US and Canada legal cannabis market targeting consumers that are users of medical and/or recreational cannabis. Novus offers cost-savings health plans for patients and businesses domestically and internationally, focused around, THC Plans that are sold in legal states and CBD Plans which are sold nationwide. All plans such as dental, vision, hearing, telemedicine, include cannabis benefits making these plans eligible for reimbursement under the Health Reimbursement Act.
Future Of Novus
The health insurance industry is expanding rapidly, internationally, the sector will grow from a revenue base of $1.2 trillion to $3.7 trillion by 2023. Novus continues to strengthen its position in the health insurance and legal cannabis marketplace through solid relationships with medical providers leaving fewer resources for potential rivals.
We invite you to further your research by clicking the icons below.
Novus Acquisition & Development Group
2665 South Bayshore Drive Suite 220
Miami, FL 33131
Phone 855-228-7355
Novus has a first-mover advantage in obtaining a lion-share of the market through its established branding initiatives and consumer loyalty before other competitors even began to move into the cannabis sector.
Unlike conventional insurance carriers, the Novus program offers significant cost-savings on legal cannabis meds and other supplemental health plans. Conflicting federal and state laws surrounding this burgeoning industry has caused widespread confusion, leading to conventional insurance companies continuing to refuse coverage of hemp, cannabidiol (CBD), medical cannabis (THC) and alternative/ integrative treatment options for patients.
The Novus model is unique, by focusing on the deficiencies of private and government health plans in the US and Canada by integrating supplemental plans that include legal cannabis meds for recreational and medicinal users.
The main reasons behind Novus’ head start in this health insurance sector can be attributed to three factors:
Since cannabis is not legal federally, many major insurance carriers will not jeopardize their multi-billion-dollar Federal Medicare/Medicaid contracts by doing business in this sector.
Insurance companies generally don’t favor meds that have not been approved by the US Food & Drug Administration (FDA).
Major carriers usually concentrate on acquiring market share as opposed to creating it.
Cap Structure as of April 1, 2019
| ||||||||||||||||||
| Shareholders | 2443 | Dec 31, 2019 |
| Corporate Profile | Click Here |
| Press Releases | Click Here |
| Filings | Click Here |
| Secured Funding Request | Click Here |
*Always review with your investment advisor prior to investing
Disclaimer and Forward-Looking Statement Click Here
We are available Monday - Friday 9:00 am - 5:00 pm (EST) Email: info@getnovusnow.com